21 Feb A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia
Dormuth CR, Fisher A, Carney G Pharmacoepidemiology & Drug Safety. 2020 https://doi.org/10.1002/pds.4957 Abstract Purpose: To describe a rapid monitoring plan to assess the impacts of a shift in drug coverage for biosimilar drugs in British Columbia following the introduction...